Therapeutic Effects of Mesalamine and Amitriptyline in IBS: a Randomized Clinical Trial
Status: Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 19 Apr 2016
Price : $35 *
At a glance
- Drugs Mesalazine (Primary) ; Amitriptyline
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 14 Apr 2016 Status changed from recruiting to withdrawn prior to enrolment due to lack of volunteer patients.
- 13 Nov 2014 Planned primary completion date changed from 1 Sep 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 13 Nov 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.